Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Deciphering cytokine-driven ADP-ribosylation signaling networks via Af1521-based mass spectrometry analysis of labile Glu/Asp-linkages.

Nature communications·2026
Same author

Benchmarking Plasma Proteomics Workflows and Their Correlation to Clinical Routine Protein Assays.

Journal of proteome research·2026
Same author

Glucocorticoid-Induced Proteome and Phosphoproteome Changes in Breast Cancer Cell Lines.

Journal of proteome research·2026
Same author

The Japanese Archipelago sheltered cave lions, not tigers, during the Late Pleistocene.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Comparative Analysis of Lysine-Specific Peptidases for Optimizing Proteomics Workflows.

Journal of proteome research·2025
Same author

Anti-Tumoral Treatment with Thioredoxin Reductase 1 Inhibitor Auranofin Fosters Regulatory T Cell and B16F10 Expansion in Mice.

Antioxidants (Basel, Switzerland)·2025

相关实验视频

Updated: Jan 16, 2026

Author Spotlight: Expression and Purification of Human Solute Carrier Transporters Using Codon-Optimized Genes
07:10

Author Spotlight: Expression and Purification of Human Solute Carrier Transporters Using Codon-Optimized Genes

Published on: September 29, 2023

4.4K

对于低细胞输入的高通量蛋白质组积分可溶性变化试验,使用一端式.

Maico Lechner1, Pierre Sabatier2,3, Jesper V Olsen4

  • 1Department of Cellular and Molecular Medicine, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Communications chemistry
|September 27, 2025
PubMed
概括

我们通过使用蛋白质组积溶性改变 (PISA) 简化了药物标参与分析. 这种方法显著减少了细胞需求和处理时间,提高了更广泛实验室应用的效率.

更多相关视频

PeptiQuick, a One-Step Incorporation of Membrane Proteins into Biotinylated Peptidiscs for Streamlined Protein Binding Assays
15:04

PeptiQuick, a One-Step Incorporation of Membrane Proteins into Biotinylated Peptidiscs for Streamlined Protein Binding Assays

Published on: November 2, 2019

11.3K
A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9
08:14

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9

Published on: August 28, 2018

8.6K

相关实验视频

Last Updated: Jan 16, 2026

Author Spotlight: Expression and Purification of Human Solute Carrier Transporters Using Codon-Optimized Genes
07:10

Author Spotlight: Expression and Purification of Human Solute Carrier Transporters Using Codon-Optimized Genes

Published on: September 29, 2023

4.4K
PeptiQuick, a One-Step Incorporation of Membrane Proteins into Biotinylated Peptidiscs for Streamlined Protein Binding Assays
15:04

PeptiQuick, a One-Step Incorporation of Membrane Proteins into Biotinylated Peptidiscs for Streamlined Protein Binding Assays

Published on: November 2, 2019

11.3K
A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9
08:14

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9

Published on: August 28, 2018

8.6K

科学领域:

  • 生物化学 生物化学
  • 蛋白质组学是指蛋白质组学.
  • 化学生物学 化学生物学

背景情况:

  • 细胞热转移试验 (CETSA) 和其基于质谱的变体,如蛋白质组积溶性改变 (PISA),对于监测药物向参与至关重要.
  • 目前的PISA方法在吞吐量,可扩展性和样本量方面存在局限性,这限制了它们的广泛使用.

研究的目的:

  • 通过整合单一提示方法,为PISA开发一个简化和可扩展的样本准备工作流程.
  • 减少样本输入要求,提高基于CETSA的药物向药物参与概况的效率和可访问性.

主要方法:

  • 结合PISA与一点方法用于简化样本准备.
  • 使用的n-Dodecyl-β-D-Maltoside (DDM) 用于细胞溶解,与质谱学和一键处理兼容.
  • 将细胞输入要求降低到每μL的200个细胞.
  • 应用一键PISA工作流程,以96井板格式进行化酶抑制剂的分析.

主要成果:

  • 在PISA中实现了显著较低的细胞要求 (低至200细胞/μL).
  • 通过一点PISA方法证明了可比的蛋白质深度和改进的可重复性.
  • 减少材料和溶剂的使用,与传统协议相比,蛋白质分解消化速度更快.
  • 在12小时内实现了从细胞处理到质谱注射的完整工作流.

结论:

  • 单一提示PISA方法为药物向参与研究提供了一种具有成本效益,快速和用户友好的方法.
  • 这种集成的工作流提高了可扩展性和可访问性,使先进的蛋白质基因分析成为更多实验室可行的.
  • 优化的工作流通过提高目标参与评估的效率来加速药物发现和开发.